Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis

American Journal of Gastroenterology

Volumn 99, Issue 3, 2004, Pages 523-526

  Burak, Kelly ^b   Angulo, Paul ^b   Pasha, Tousif M ^b   Egan, Kathleen ^b   Petz, Jan ^b   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; BILE DUCT CARCINOMA; CANCER INCIDENCE; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HUMAN; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROCTOCOLECTOMY; RISK ASSESSMENT; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 1942440342     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.04067.x     Document Type: Article

References (25)

1. Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology 1999;30:325-32.
2. Farges O, Malassagne B, Sebagh M, et al. Primary sclerosing cholangitis: Liver transplantation or biliary surgery. Surgery 1995;117:146-55.
3. Helzberg JH, Peterson JM, Boyer JL. Improved survival with primary sclerosing cholangitis. Gastroenterology 1987;92:1869-75.
4. Farrant JM, Hayllar KM, Wilkinson ML, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100:1710-7.
5. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610-5.
6. Boberg KM, Schrumpf E, Fausa O, et al. Hepatobiliary diseases in ulcerative colitis: An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. Scand J Gastroenterol 1994;29:744-52.
7. Broome U, Lofberg R, Veress R, et al. Primary sclerosing cholangitis and ulcerative colitis: Indicator of increased neoplastic potential. Hepatology 1995;22:1404-8.
8. Miros M, Kerlin P, Walker N, et al. Predicting CCA in patients with primary sclerosing cholangitis before transplantation. Gut 1995;32:1369-73.
9. Rosen CB, Nagorney DM, Wiesner RH, et al. CCA complicating primary sclerosing cholangitis. Ann Surg 1991;213:21-5.
10. Knechtle SJ, D'Alessandro AM, Harms BA, et al. Relationship between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 1995;118:615-20.
11. Nashan B, Schlitt HJ, Tusch G, et al. Biliary malignancies in primary sclerosing cholangitis: Timing for liver transplantation. Hepatology 1996;23:1105-11.
12. Kornfeld D, Ekbon A, Ihre T. Survival and risk of CCA in patients with primary sclerosing cholangitis. Scand J Gastroenterol 1997;32:1042-5.
13. Schrupmf E, Abdelnoor M, Fausa O, et al. Risk factors in primary sclerosing cholangitis. J Hepatol 1994;21:1061-6.
14. Aadland E, Schrumpf E, Fausa O, et al. Primary sclerosing cholangitis: A long-term follow-up study. Scand J Gastroenterol 1987;22:655-64.
15. Berquist A, Ekbom A, Olsson R, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321-7.
16. Chalasani N, Baluyut A, Ismail A, et al. CCA in patients with primary sclerosing cholangitis: A multicenter case-control study. Hepatology 2000;31:7-11.
17. Nichols JC, Gores GJ, LaRusso NF, et al. Diagnostic role of serum CA 19-9 for CCA in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993;68:874-9.
18. Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of CCA in primary sclerosing cholangitis. Gastroenterology 1995;108:865-9.
19. Bjornsson E, Kilander A, Olsson R. CA 19-9 and CEA are unreliable markers for CCA in patients with primary sclerosing cholangitis. Liver 1999;19:501-8.
20. de Groen PC. CCA in primary sclerosing cholangitis: Who is at risk and how do we screen? Hepatology 2000;31:247-8.
21. Wiesner RH, Grambsch PM, Dickson ER, et al. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology 1989;10:430-6.
22. MacCarty RL, LaRusso NF, Wiesner RH, et al. Primary sclerosing cholangitis findings on cholangiography and pancreatography. Radiology 1983;149:39-44.
23. Ludwig J, LaRusso NF, Wiesner RH. Primary sclerosing cholangitis. In: Peters RL, Craig JR, eds. Liver pathology. Contemporary issues in surgical pathology. New York: Churchill Livingstone, 1986:193-213.
24. Rosenbaum PR. Optimal matching for observational studies. J Am Stat Assoc 1989;84:1024-32.
25. Bergquist A, Glaumann H, Persson B, et al. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case-control study. Hepatology 1998;27:311-6.